Ganaway, Carlito B.

HRN: 26-00-58  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/15/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/15/2024
10/21/2024
IVTT
1.5 G
Q6
Sepsis, Infected Wound
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: